A comparative evaluation of gemtuzumab ozogamicin  + daunorubicin-cytarabine and other treatments for newly diagnosed acute myeloid leukemia
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - November 19, 2018 Category: Cancer & Oncology Authors: Ajibade O Ashaye Zarmina Khankhel Yingxin Xu Kyle Fahrbach Ruth Mokgokong Michelle E Orme Kathryn Lang Joseph C Cappelleri Carla Mamolo Source Type: research

A review discussing the use of polyethylene glycol microspheres in the treatment of hepatocellular carcinoma
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - November 16, 2018 Category: Cancer & Oncology Authors: Giammaria Fiorentini Donatella Sarti Riccardo Carandina Luca Mulazzani Cinzia Mincarelli Roberto Candelari Renato Argir ò Caterina Fiorentini Camillo Aliberti Source Type: research

Neutrophil-to-lymphocyte ratio is superior to platelet-to-lymphocyte ratio as a prognostic predictor   in advanced non-small-cell lung cancer treated with first-line platinum-based chemotherapy
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - November 15, 2018 Category: Cancer & Oncology Authors: Dong Guo Minghuan Li Dawei Chen Wang Jing Hui Zhu Lei Fu Li Kong Jinbo Yue Jinming Yu Source Type: research

Apalutamide and its use in the treatment of prostate cancer
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - November 14, 2018 Category: Cancer & Oncology Authors: Hala T Borno Eric J Small Source Type: research

Assessment of the 8th edition of TNM staging system for gastric cancer: the results from the SEER and a single-institution database
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - November 14, 2018 Category: Cancer & Oncology Authors: Bochao Zhao Jingting Zhang Jiale Zhang Rui Luo Zhenning Wang Huimian Xu Baojun Huang Source Type: research

Real-world treatment patterns and outcomes of patients with stage IV squamous cell carcinoma of the head and neck
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - November 14, 2018 Category: Cancer & Oncology Authors: Katherine Byrne Giovanni Zanotti Pamela Hallworth Adam Roughley Jean-Francois Martini Roberto Uehara Shrividya Iyer Source Type: research

Pediatric ependymoma: current treatment and newer therapeutic insights
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - November 12, 2018 Category: Cancer & Oncology Authors: Soumen Khatua Ross Magnum Kelsey C Bertrand Wafik Zaky David McCall Stephen C Mack Source Type: research

NFIX downregulation independently predicts poor prognosis in lung adenocarcinoma, but not in squamous cell carcinoma
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - November 12, 2018 Category: Cancer & Oncology Authors: Jun Ge Hang Dong Ye Yang Bin Liu Min Zheng Qing Cheng Li Peng Juan Li Source Type: research

Breast microcalcifications: biological and diagnostic perspectives
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - November 9, 2018 Category: Cancer & Oncology Authors: Rita Bonfiglio Manuel Scimeca Nicoletta Urbano Elena Bonanno Orazio Schillaci Source Type: research

Combination immunotherapy in metastatic renal cell carcinoma. Are we leaving something back?
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - November 9, 2018 Category: Cancer & Oncology Authors: Vincenzo Di Nunno Lidia Gatto Benedetta Fragomeno Marta Cubelli Elisabetta Nobili Ida Romano Matteo Santoni Salvatore Pisconti Rodolfo Montironi Francesco Massari Source Type: research

Eribulin in the treatment of advanced breast cancer: real-world scenario from 39 Italian centers – ESEMPiO study
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - November 9, 2018 Category: Cancer & Oncology Authors: Sandro Barni Luca Livraghi Maria Morritti Patrizia Vici Andrea Michelotti Saverio Cinieri Caterina Fontanella Luca Porcu Lucia Del Mastro Fabio Puglisi Source Type: research

Tumor clonality and resistance mechanisms in EGFR mutation-positive non-small-cell lung cancer: implications for therapeutic sequencing
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - November 8, 2018 Category: Cancer & Oncology Authors: Shinji Kohsaka Mark Petronczki Flavio Solca Makoto Maemondo Source Type: research

Acalabrutinib and its use in treatment of chronic lymphocytic leukemia
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - November 1, 2018 Category: Cancer & Oncology Authors: Yasir Khan Susan O'Brien Source Type: research

S6K2 promises an important therapeutic potential for cancer
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - November 1, 2018 Category: Cancer & Oncology Authors: Nurettin İlter Sever Sevilay Cengiz Şahin Source Type: research

Maintenance avelumab versus continuation of first-line chemotherapy in gastric cancer: JAVELIN Gastric 100 study design
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - October 31, 2018 Category: Cancer & Oncology Authors: Markus Moehler Min-Hee Ryu Mikhail Dvorkin Keun-Wook Lee Hasan Ş Coşkun Rachel Wong Hyun C Chung Artem Poltoratsky Akihito Tsuji Chia Jui Yen Alina S Muntean Samuel Le Sourd Gina M Vaccaro Lindsay Overton Narikazu Boku Zev A Wainberg Manish Patel Maitre Source Type: research

Inflammatory breast cancer outcomes by breast cancer subtype: a population-based study
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - October 31, 2018 Category: Cancer & Oncology Authors: San-Gang Wu Wen-Wen Zhang Jun Wang Yong Dong Jia-Yuan Sun Yong-Xiong Chen Zhen-Yu He Source Type: research

Real-world use of bevacizumab in metastatic colorectal, metastatic breast, advanced ovarian and cervical cancer: a systematic literature review
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - October 31, 2018 Category: Cancer & Oncology Authors: Sherif Raouf Gianfilippo Bertelli Agnes Ograbek Polly Field Irwin Tran Source Type: research

Extending resectability of hilar cholangiocarcinomas: how can it be assessed and improved?
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - October 31, 2018 Category: Cancer & Oncology Authors: Marcello Donati Axel Stang Gregor A Stavrou Francesco Basile Karl J Oldhafer Source Type: research

ATLANTIS: a Phase III study of lurbinectedin/doxorubicin versus topotecan or cyclophosphamide/doxorubicin/vincristine in patients with small-cell lung cancer who have failed one prior platinum-containing line
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - October 26, 2018 Category: Cancer & Oncology Authors: Anna F Farago Benjamin J Drapkin Jose Antonio Lopez-Vilarino de Ramos Carlos M Galmarini Rafael N úñez Carmen Kahatt Luis Paz-Ares Source Type: research

Sequential treatment with afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer: an observational study
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - October 19, 2018 Category: Cancer & Oncology Authors: Maximilian J Hochmair Alessandro Morabito Desiree Hao Cheng-Ta Yang Ross A Soo James C-H Yang Rasim Gucalp Balazs Halmos Lara Wang Amanda Golembesky Angela M ärten Tanja Cufer Source Type: research

A remarkable insight into the cancer journey of Barbara Moss
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - October 19, 2018 Category: Cancer & Oncology Authors: Barbara Moss Source Type: research

Nivolumab and ipilimumab: immunotherapy for treatment of malignant melanoma
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - October 18, 2018 Category: Cancer & Oncology Authors: Nicole A Carreau Anna C Pavlick Source Type: research

GEN-1 immunotherapy for the treatment of ovarian cancer
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - October 16, 2018 Category: Cancer & Oncology Authors: Premal H Thaker Nicholas Borys Jason Fewell Khursheed Anwer Source Type: research

Cost-utility of afatinib and gefitinib as first-line treatment for EGFR-mutated advanced non-small-cell lung cancer
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - October 15, 2018 Category: Cancer & Oncology Authors: Hao Wang Chenxin Zeng Xin Li Youjie Wang Xinyi Li Weihong Ge Source Type: research

Stage III melanoma incidence and impact of transitioning to the 8th AJCC staging system: a US population-based study
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - October 15, 2018 Category: Cancer & Oncology Authors: Ahmad Tarhini Sameer Ghate Raluca Ionescu-Ittu Sherry Shi Antonio Nakasato Briana Ndife Francois Lalibert é Rebecca Burne Mei Sheng Duh Source Type: research

HTX-019: polysorbate 80- and synthetic surfactant-free neurokinin 1 receptor antagonist for chemotherapy-induced nausea and vomiting prophylaxis
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - October 11, 2018 Category: Cancer & Oncology Authors: Rudolph M Navari Source Type: research

Hypersensitivity and infusion-site adverse events with intravenous fosaprepitant after anthracycline-containing chemotherapy: a retrospective study
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - October 10, 2018 Category: Cancer & Oncology Authors: Ralph Boccia Robert B Geller Neil Clendeninn Thomas Ottoboni Source Type: research

Beyond BCG: the approaching era of personalised bladder-sparing therapies for non-muscle-invasive urothelial cancers
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - October 10, 2018 Category: Cancer & Oncology Authors: Francis P Young David Ende Richard J Epstein Source Type: research

Corrigendum
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - October 10, 2018 Category: Cancer & Oncology Source Type: research

Comparative immunogenicity assessment of biosimilars
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - October 3, 2018 Category: Cancer & Oncology Authors: Thomas Schreitm üller Bettina Barton Artem Zharkov Georgios Bakalos Source Type: research

The rationale for combination therapy in patients with aggressive B-cell non-Hodgkin lymphoma: ten questions
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - October 3, 2018 Category: Cancer & Oncology Authors: Wojciech Jurczak Monika D ługosz-Danecka Fernando Rivas Navarro Source Type: research

Paclitaxel reversed trastuzumab resistance via regulating JUN in human gastric cancer cells identified by FAN analysis
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - September 28, 2018 Category: Cancer & Oncology Authors: Zhe Wang Fei Zou Yingying Tian Bowen Xiang Baoli Qin Yefu Liu Source Type: research

Treatment preferences in human papillomavirus-associated oropharyngeal cancer
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - September 28, 2018 Category: Cancer & Oncology Authors: Melina J Windon Gypsyamber D'Souza Carole Fakhry Source Type: research

Treatment patterns and outcomes for patients with advanced melanoma in US oncology clinical practices
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - September 25, 2018 Category: Cancer & Oncology Authors: Eric D Whitman Frank Xiaoqing Liu Xiting Cao Scott J Diede Amin Haiderali Amy P Abernethy Source Type: research

Ponatinib in the treatment of chronic myeloid leukemia and philadelphia chromosome positive acute lymphoblastic leukemia
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - September 25, 2018 Category: Cancer & Oncology Authors: Carolina Pavlovsky Onyee Chan Chetasi Talati Javier Pinilla-Ibarz Source Type: research

Nomograms to predict survival rates for esophageal cancer patients with malignant behaviors based on ICD-0-3
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - September 20, 2018 Category: Cancer & Oncology Authors: Yuchen Sun Jizhao Wang Yingchao Li Shupei Pan Tian Yang Xuanzi Sun Ya Wang Xiaobo Shi Xu Zhao Xiaozhi Zhang Source Type: research

Serum microRNA as potential biomarker to detect breast atypical hyperplasia and early-stage breast cancer
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - September 17, 2018 Category: Cancer & Oncology Authors: Xuefeng An Hong Quan Jinhui Lv Lingyu Meng Cheng Wang Zuoren Yu Jing Han Source Type: research

Pre-emptive skin treatments to prevent skin toxicity caused by anti-EGFR antibody: the real-world evidence in Japan
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - September 14, 2018 Category: Cancer & Oncology Authors: Naoya Yamazaki Yumi Oomuku Izumi Mishiro Junpei Soeda Source Type: research

Roles of miR-200 family members in lung cancer: more than tumor suppressors
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - September 13, 2018 Category: Cancer & Oncology Authors: Cong Liu Wei Hu Lin-Lin Li Yu-Xuan Wang Qun Zhou Feng Zhang Yi-Yan Song-Yang Wei Zhu Cheng-Chao Sun De-Jia Li Source Type: research

Treatment satisfaction in women receiving palbociclib combination therapies for advanced/metastatic breast cancer
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - September 12, 2018 Category: Cancer & Oncology Authors: Christina Darden Debanjali Mitra David McSorley Kimberly Davis Juliet Band Shrividya Iyer Source Type: research

The Italian Mastocytosis Registry: 6-year experience from a hospital-based registry
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - September 12, 2018 Category: Cancer & Oncology Authors: Serena Merante Virginia V Ferretti Chiara Elena Valeria Brazzelli Roberta Zanotti Iria Ner Diomira Magliacane Anna Belloni Fortina Forer Ingeborg Elide A Pastorello Lisa Pieri Cristina Papayannidis Marina Mauro Federica Grifoni Roberto Minelli Elena Guggi Source Type: research

Enzalutamide after chemotherapy in advanced castration-resistant prostate cancer: the Italian Named Patient Program
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - September 12, 2018 Category: Cancer & Oncology Authors: Francesca Maines Ugo De Giorgi Giuseppe Procopio Gaetano Facchini Lucia Fratino Roberto Sabbatini Donatello Gasparro Umberto Basso Claudia Mosillo Enrico Campadelli Francesco Massari Teodoro Sava Suzana Sirotova Caterina Messina Sarah Scagliarini Vincenza Source Type: research

BRAFi/MEKi in patients with metastatic melanoma: predictive factors of complete response
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - September 10, 2018 Category: Cancer & Oncology Authors: Simone Ribero Ottavia Malavenda Paolo Fava Chiara Astrua Elena Marra Simona Osella-Abate Martina Sanlorenzo Virginia Caliendo Maria Teresa Fierro Pietro Quaglino Source Type: research

Survival strategies of cancerous cells: a novel perspective
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - September 7, 2018 Category: Cancer & Oncology Authors: Sachin C Sarode Nilesh Kumar Sharma Gargi S Sarode Pritish Nilendu Shankargouda Patil Source Type: research

Pancreatic cancer: let us focus on cachexia, not just sarcopenia!
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - September 7, 2018 Category: Cancer & Oncology Authors: Savio George Barreto Source Type: research

Management of challenging immune-related gastrointestinal adverse events associated with immune checkpoint inhibitors
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - September 6, 2018 Category: Cancer & Oncology Authors: Yasuo Hamamoto Natalya Shin Tomohiro Hoshino Takanori Kanai Source Type: research

Reasoning the effect of immunotherapy after chemoradiation in the PACIFIC trial
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - September 3, 2018 Category: Cancer & Oncology Authors: Ajaz Bulbul Emilio Araujo-Mino Source Type: research

Antibody –drug conjugates in triple negative breast cancer
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - September 3, 2018 Category: Cancer & Oncology Authors: Nancy Tray Sylvia Adams Francisco J Esteva Source Type: research

Mammaprint ™: a comprehensive review
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - August 29, 2018 Category: Cancer & Oncology Authors: Mariana Brand ão Noam Pond é Martine Piccart-Gebhart Source Type: research

Harnessing the CD8+ T-cell subsets with stemness for tumor immunotherapy
Future Oncology,Volume 14, Issue 24, Page 2433-2436, October 2018. (Source: Future Oncology)
Source: Future Oncology - August 24, 2018 Category: Cancer & Oncology Authors: Wei Wang Yukai He Sha Wu Source Type: research